Market Introduction
Pulmonary or respiratory devices are mostly used for the patients suffering from the respiratory diseases such as chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases to remove mucus and secretions from the airways or the respiratory tract. These medical devices are focused on diagnosis, control, treatment, management, and evaluation of the problems associated with the respiratory tract.
Market Overview and Dynamics
The North America pulmonary devices market is expected to reach US$ 16,637.44 million by 2027 from US$ 7,581.04 million in 2019. The market is anticipated to grow at a CAGR of 10.3% during 2019–2027. The rising number of COVID-19 cases and increasing prevalence of respiratory diseases are the major factors expected to boost the growth of the pulmonary devices market in North America. However, the market is likely to get impacted by the risk factor such as unfavorable reimbursement scenario associated with respiratory devices during the forecast period.
Key Market Segments
In terms of type, the therapeutic devices segment accounted for the largest share of the North America pulmonary devices market in 2019. In terms of application, chronic obstructive pulmonary disease (COPD) segment accounted for the largest share of the North America pulmonary devices market in 2019. In terms of end user, the hospitals segment accounted for the largest share of the North America pulmonary devices market in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the North America pulmonary devices market report are the World Health Organization (WHO), US Department of Health and Human Services, Centers of Disease Control and Prevention (CDC), and others.
Reasons to buy report
- It provides understanding of the North America, pulmonary devices market landscape and identifies pulmonary devices market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America pulmonary devices market.
- It helps efficiently plan merger and acquisition, and partnership deals in the pulmonary devices market by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of pulmonary devices market performance of various segments pertaining to the North America pulmonary devices market.
- It provides pulmonary devices market revenue forecast of the market based on various segments for the period from 2019 to 2027.
NORTH AMERICA PULMONARY DEVICES MARKET SEGMENTATION
By Type
- Therapeutic Devices
- Consumables and Accessories
- Diagnostic Devices
- Monitoring Devices
By Application
- Chronic Obstructive Pulmonary Disease (COPD)
- Sleep Apnea
- Asthma
- Infectious Diseases
- Others
By End User
- Hospitals
- Home Care Settings
- Ambulatory Care Centers
By Country
- US
- Canada
- Mexico
Company Profiles
North America Pulmonary Devices Market Strategic Insights
North America Pulmonary Devices Market Report Highlights
| Report Attribute | Details |
| Market size in 2019 | US$ 7,581.04 Million |
| Market Size by 2027 | US$ 16,637.44 Million |
| CAGR (2019 - 2027) | 10.3% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Type
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
North America Pulmonary Devices Market Country and Regional Insights
